Last reviewed · How we verify

NCT03442283

Supplemental Vitamins and Minerals for CVD Prevention and Treatment: Systematic Review and Meta-analyses of the Data (Meta-analyses and RCTs) Published Since 2012

Status unknown Last updated 22 February 2018
What this trial tests

trial testing Vitamin mineral supplementation in Cardiovascular Diseases in 1 participant. Status unknown.

Timeline
1 July 2016
Primary endpoint
1 April 2018
1 June 2018

Quick facts

Lead sponsorUniversity of Toronto
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1
Start date1 July 2016
Primary completion1 April 2018
Estimated completion1 June 2018

Drugs / interventions tested

Conditions studied

Sponsor

University of Toronto

Who can join

18 and older, any sex, with Cardiovascular Diseases. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The use of vitamin and mineral supplementation has historically been to treat and prevent micronutrient deficiencies. In recent years, however, and with their widespread use, the interest has shifted toward a possible role in the prevention and treatment of chronic diseases. The investigators will review and perform meta-analyses of vitamin and mineral supplementation trials in relation to cardiovascular disease. Publications from 2012, both before and including the US Preventive Service Task Force (USPSTF) 2014 review, will be included in the review.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other University of Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03442283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing